Literature DB >> 34118181

The splanchnic reservoir: an oasis for blood volume in heart failure with preserved ejection fraction?

Ravi B Patel1, Sanjiv J Shah1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34118181      PMCID： PMC8991301          DOI： 10.1002/ejhf.2268

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   17.349


× No keyword cloud information.
  13 in total

1.  Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.

Authors:  Shmuel Schwartzenberg; Margaret M Redfield; Aaron M From; Paul Sorajja; Rick A Nishimura; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2012-01-31       Impact factor: 24.094

2.  Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation.

Authors:  Catherine Fallick; Paul A Sobotka; Mark E Dunlap
Journal:  Circ Heart Fail       Date:  2011-09       Impact factor: 8.790

3.  Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.

Authors:  Marat Fudim; Petr Neuzil; Filip Malek; Zoar J Engelman; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2021-04-20       Impact factor: 24.094

4.  Effects of splanchnic nerve stimulation on cardiac preload, afterload, and output in cats.

Authors:  C V Greenway; I R Innes
Journal:  Circ Res       Date:  1980-02       Impact factor: 17.367

5.  Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction.

Authors:  Julio A Chirinos; Francisco Londono-Hoyos; Payman Zamani; Melissa Beraun; Philip Haines; Izzah Vasim; Swapna Varakantam; Timothy S Phan; Thomas P Cappola; Kenneth B Margulies; Raymond R Townsend; Patrick Segers
Journal:  Eur J Heart Fail       Date:  2017-05-25       Impact factor: 15.534

6.  Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.

Authors:  S Y Wang; D E Manyari; N Scott-Douglas; O A Smiseth; E R Smith; J V Tyberg
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

7.  Splanchnic Nerve Block for Chronic Heart Failure.

Authors:  Marat Fudim; Richard L Boortz-Marx; Arun Ganesh; Adam D DeVore; Chetan B Patel; Joseph G Rogers; Aubrie Coburn; Inneke Johnson; Amanda Paul; Brian J Coyne; Sunil V Rao; J Antonio Gutierrez; Todd L Kiefer; David F Kong; Cynthia L Green; W Schuyler Jones; G Michael Felker; Adrian F Hernandez; Manesh R Patel
Journal:  JACC Heart Fail       Date:  2020-06-10       Impact factor: 12.035

8.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.

Authors:  Margaret M Redfield; Kevin J Anstrom; James A Levine; Gabe A Koepp; Barry A Borlaug; Horng H Chen; Martin M LeWinter; Susan M Joseph; Sanjiv J Shah; Marc J Semigran; G Michael Felker; Robert T Cole; Gordon R Reeves; Ryan J Tedford; W H Wilson Tang; Steven E McNulty; Eric J Velazquez; Monica R Shah; Eugene Braunwald
Journal:  N Engl J Med       Date:  2015-11-08       Impact factor: 91.245

9.  Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trial.

Authors:  Filip Málek; Piotr Gajewski; Robert Zymliński; Dariusz Janczak; Mariusz Chabowski; Marat Fudim; Tomas Martinca; Petr Neužil; Jan Biegus; Martin Mates; Andreas Krüger; Ivo Skalský; Anisha Bapna; Zoar J Engelman; Piotr P Ponikowski
Journal:  Eur J Heart Fail       Date:  2021-07-16       Impact factor: 15.534

10.  Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study.

Authors:  Ravi B Patel; Carolyn S P Lam; Sara Svedlund; Antti Saraste; Camilla Hage; Ru-San Tan; Lauren Beussink-Nelson; Jasper Tromp; Cynthia Sanchez; Joyce Njoroge; Stanley A Swat; Ulrika Ljung Faxén; Maria Lagerstrom Fermer; Ashwin Venkateshvaran; Li-Ming Gan; Lars H Lund; Sanjiv J Shah
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.